US FDA Commissioner Scott Gottlieb is worried there may be a looming downside to increasing salaries at the agency, namely a mass migration of staff.
Gottlieb is worried not about movement out of FDA to academia or industry, but rather within the agency itself – to offices or centers with budgets that can afford higher salaries and away from those that cannot, he told told the Alliance for a Stronger FDA, a
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?